News

Intriguing Reports On Breakthroughs, Discoveries, and Novelties In DNA Testing

Ancestry And Family Trees

Ancestry Plans To Link DNA Results And Family Trees

April 2, 2019

Ancestry.com is currently beta testing its new feature designed to connect personal DNA reports with family trees and provide its users with more information regarding their lineages and ethnicity profiles. Read all about this exciting new addition and find out how to test the beta version of ThruLines in this short report.

MyHeritage Automatic Clustering

MyHeritage Introduces Automatic Clustering

March 5, 2019

MyHeritage has just released a new feature called AutoClusters that groups different genetic relatives discovered by your DNA sequencing into clusters with the same shared ancestor. Apart from providing you with a clearer final report, this tech will also give you better explanations of each individual connection. Read more in this article.

MyHeritage Reveals The Theory Of Family Relativity

MyHeritage Reveals The Theory Of Family Relativity

March 2, 2019

MyHeritage has just introduced a groundbreaking new technology called the Theory of Family Relativity that aims to combine billions of historical records with millions of family trees in order to better explain the biological DNA connections shown by its at-home DNA tests. Read more in this short overview.

Ancestry com African American migration

Ancestry.com Releases New Data For Those From The African Diaspora

February 27, 2019

Ancestry has just released new data relevant to individuals from the African diaspora. Its users received 94 new and updated communities, which should reveal new information about the genetic roots of African Americans and Afro-Caribbeans as well as the migration patterns of their ancestors through history. Read more in this short report.

Genetic Prerequisites For Osteoporosis

23andMe Confirms Genetic Prerequisites For Osteoporosis

February 7, 2019

23andMe’s genetic database provided the necessary samples for the latest study related to genetic prerequisites for low bone density and the development of osteoporosis. The main goal of the study was to find the causal connection between the genetic variations and the illness and help develop potential treatments and identify patients earlier.

23andMe Colorectal Cancer Test

23andMe Gets The Green Light For Its Colorectal Cancer Test

January 29, 2019

After clearing its test for three variants in BRCA1 and BRCA2 genes related to breast cancer, the FDA has also greenlit 23andMe’s test for two variants that influence MUTYH-associated polyposis. This is a rare condition that generally increases the risk of developing colorectal cancer. Learn more about this test in our report.

FDA Approves 23andMe dna

FDA Approves 23andMe’s DTC Genetic Test For Medication Metabolism

November 6, 2018

23andMe’s Personal Genome Service Pharmacogenetic Reports test just got approved by the FDA. The first direct-to-customer screening option of its kind to secure FDA approval, the test is designed to detect potential genetic variants in charge of one’s ability to metabolize certain medications. Learn more about this big win for 23andMe in this article.

Embark Uncovers Why Dogs Have Blue Eyes

Embark Uncovers Why Dogs Have Blue Eyes

October 11, 2018

Embark has published its first scientific research, which conveys the company’s commitment to ending all preventable diseases in dogs. The project, which is the biggest initiative of its kind to date, was launched to answer why some dogs have blue eyes. Learn more about this exciting genome-wide association study in this article.

Join our mailing list to receive exclusive updates, giveaways and coupon codes directly to your inbox.